How many biological replicates are generally good for publishing SCI papers on metabolomics and transcriptomics?

When submitting an SCI paper involving high-throughput omics experiments such as metabolomics and transcriptomics, the number of biological replicates is crucial. This directly affects the credibility of the paper and its potential for publication. Here are some general recommendations:

 

I. Recommended Number of Replicates (Biological Replicates)

1. For basic research SCI (medium IF, around 5): At least 3–5 biological replicates per group, with 3 being the minimum standard and 5 being more reliable.

2. For high-quality SCI (IF > 8) or top journals with strict requirements: It is recommended to have 6 or more biological replicates.

3. If the sample heterogeneity is high (such as clinical samples or human tissues), more replicates are suggested, like 8–10, to increase statistical power.

 

II. Considerations

1. Biological replicates ≠ Technical replicates: They must be independent individuals or independent experimental batches, not the same sample measured three times.

2. Journal/Reviewer Sensitivities: 3 replicates can pass the initial review, but reviewers often point out 'sample size is too small'; especially when data variability is high, low replicate numbers make differential analysis insignificant.

 

III. Overall Recommendations

1. If your budget and sample size allow, strive for 5 or more;

2. If you can only do 3, ensure high data quality and a stable technical platform, and consider additional experiments to strengthen the findings (such as qPCR, WB verification);

3. If dealing with human samples, consider starting with 6;

4. Before submission, it is best to check recent omics articles in your target journal to see how many replicates were used, to better gauge expectations.

 

Beyotime Biotechnology - A high-quality service provider for bioproduct characterization and multi-omics mass spectrometry analysis

 

Related Services:

Metabolomics